Increased interleukin‐9 levels in sera, muscle and skin of patients with dermatomyositis

Table S1. Clinical and laboratory characteristics of patients with dermatomyositis, according to serum interleukin-9 levels* Table S2. Clinical and serological features of patients with anti-Mi-2 antibody Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.